Citation Impact
Citing Papers
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity
2007 StandoutNobel
Mode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI Inhibitor
2012
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial
2008
QM/MM Methods for Biomolecular Systems
2009 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Analysis of the Steps Involved in Dengue Virus Entry into Host Cells
1999
Comparison of Treatment with Imipenem vs. Ceftazidime as a Predisposing Factor for Nosocomial Acquisition of Stenotrophomonas maltophilia: A Historical Cohort Study
1997
Activity of trimethoprim/ sulfamethoxazole plus polymyxin B against multiresistantStenotrophomonas maltophilia
1996
Asymmetric Synthesis of Natural Product Inspired Tricyclic Benzopyrones by an Organocatalyzed Annulation Reaction
2008
A review of the antimicrobial activity of clavulanate
2003
Use of Analogues of Methionine and Methionyl Adenylate to Sample Conformational Changes During Catalysis in Escherichia coli Methionyl-tRNA Synthetase
2003
Topical Retapamulin Ointment, 1%, versus Sodium Fusidate Ointment, 2%, for Impetigo: A Randomized, Observer-Blinded, Noninferiority Study
2007
Lewis Base Catalyzed [4+2] Annulation of Electron‐Deficient Chromone‐Derived Heterodienes and Acetylenes
2011
Marine natural products
1990 Standout
Drugs for bad bugs: confronting the challenges of antibacterial discovery
2006 Standout
Antituberculosis drugs: Ten years of research
2007
The Science of Antibiotic Discovery
2020 Standout
Design and Synthesis of Aryl Ether Inhibitors of the Bacillus Anthracis Enoyl‐ACP Reductase
2008
Inhibiting Bacterial Fatty Acid Synthesis
2006
Enzymatic assembly of carbon–carbon bonds via iron-catalysed sp3 C–H functionalization
2018 StandoutNatureNobel
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey
2005
U2504 Determines the Species Specificity of the A-Site Cleft Antibiotics:
2009 StandoutNobel
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Post-antibiotic and post- -lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum -lactamase-producing Gram-negative bacteria
2004
Bacteremia Due to Stenotrophomonas (Xanthomonas) maltophilia: A Prospective, Multicenter Study of 91 Episodes
1996
Sequential assembly of the septal cell envelope prior to V snapping in Corynebacterium glutamicum
2019 StandoutNobel
Penicillin-derived inhibitors that simultaneously target both metallo- and serine-β-lactamases
2004
The 1.5-Å Structure of Chryseobacterium meningosepticum Zinc β-Lactamase in Complex with the Inhibitor, D-Captopril
2003
Direct transition metal-catalyzed functionalization of heteroaromatic compounds
2007 Standout
New leads of metallo-β-lactamase inhibitors from structure-based pharmacophore design
2005
Catalytic asymmetric synthesis of chromenes and tetrahydroquinolines via sequential allylic alkylation and intramolecular Heck coupling
2012 StandoutNobel
Genetic strategies for antibacterial drug discovery
2003
β-Lactams and β-Lactamase Inhibitors: An Overview
2016 Standout
A Riboswitch-Based Inducible Gene Expression System for Mycobacteria
2012 StandoutNobel
New aspects of natural products in drug discovery
2007
Recent Progress in Coupling of Two Heteroarenes
2011
Structural insights into Staphylococcus aureus enoyl‐ACP reductase (FabI), in complex with NADP and triclosan
2009
Discovery of a potent and selective series of pyrazole bacterial methionyl-tRNA synthetase inhibitors
2003
Implementation of permeation rules leads to a FabI inhibitor with activity against Gram-negative pathogens
2019
In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest
1997
The role of genomics in antimicrobial discovery
2003
Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms
2014
Transition‐Metal‐Catalyzed Direct Arylation of (Hetero)Arenes by CH Bond Cleavage
2009 Standout
Recent advances in understanding the antibacterial properties of flavonoids
2011 Standout
Stenotrophomonas maltophilia Ocular Infections
1996
Bacterial Resistance and Impetigo Treatment Trends: A Review
2012
The Crystal Structure of Yeast Fatty Acid Synthase, a Cellular Machine with Eight Active Sites Working Together
2007 StandoutNobel
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Beyond Directing Groups: Transition‐Metal‐Catalyzed CH Activation of Simple Arenes
2012 Standout
Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA)
2003
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
beta-Lactamases in laboratory and clinical resistance
1995
Finding the gems using genomic discovery: antibacterial drug discovery strategies – the successes and the challenges
2004
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model
1996
DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells
2003 StandoutNobel
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Efficient and Practical Synthesis of 4(5)-Aryl-1H-imidazoles and 2,4(5)-Diaryl-1H-imidazoles via Highly Selective Palladium-Catalyzed Arylation Reactions
2007
Bond Formations between Two Nucleophiles: Transition Metal Catalyzed Oxidative Cross-Coupling Reactions
2011 Standout
Cross‐Coupling Reactions on Azoles with Two and More Heteroatoms
2006
A Click Chemistry Approach to Pleuromutilin Conjugates with Nucleosides or Acyclic Nucleoside Derivatives and Their Binding to the Bacterial Ribosome
2008
Oxidative Coupling between Two Hydrocarbons: An Update of Recent C–H Functionalizations
2015 Standout
Hydroamination: Direct Addition of Amines to Alkenes and Alkynes
2008 Standout
Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia
1995
Mild metal-catalyzed C–H activation: examples and concepts
2016 Standout
Retapamulin: A Semisynthetic Pleuromutilin Compound for Topical Treatment of Skin Infections in Adults and Children
2007
Phosphine Organocatalysis
2018 Standout
Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors
2018
The Sonogashira Reaction: A Booming Methodology in Synthetic Organic Chemistry
2007 Standout
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Inhibitor Binding by Metallo-β-lactamase IMP-1 from Pseudomonas aeruginosa: Quantum Mechanical/Molecular Mechanical Simulations
2007
Regioselective Addition of Mesitol to a 2,4-Dichloropyridine
2008
The conjugate addition of enantiomerically pure lithium amides as homochiral ammonia equivalents: scope, limitations and synthetic applications
2005
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Aryl−Aryl Bond Formation by Transition-Metal-Catalyzed Direct Arylation
2007 Standout
Discovery of aminoacyl-tRNA synthetase activity through cell-surface display of noncanonical amino acids
2006 StandoutNobel
Three Decades of β-Lactamase Inhibitors
2010 Standout
Computationally designed peptide macrocycle inhibitors of New Delhi metallo-β-lactamase 1
2021 StandoutNobel
Structure-based discovery of β 2 -adrenergic receptor ligands
2009 StandoutNobel
Reengineering Antibiotics to Combat Bacterial Resistance: Click Chemistry [1,2,3]‐Triazole Vancomycin Dimers with Potent Activity against MRSA and VRE
2016 StandoutNobel
Structural basis for cross-resistance to ribosomal PTC antibiotics
2008 StandoutNobel
Metallo-β-Lactamases: the Quiet before the Storm?
2005
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
Regioselective Functionalization of the Imidazole Ring via Transition Metal‐Catalyzed CN and CC Bond Forming Reactions
2010
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
Natural product inhibitors of fatty acid biosynthesis: synthesis of the marine microbial metabolites pseudopyronines A and B and evaluation of their anti-infective activities
2007
Tandem amine propargylation-Sonogashira reactions: new three-component coupling leading to functionalized substituted propargylic amines
2004
The Halogen Bond
2016 Standout
In vitrosusceptibility of 124Xanthomonas maltophilia(Stenotrophomonas maltophilia) isolates
1996
Retapamulin
2007
Enzymatic aminoacylation of tRNA with unnatural amino acids
2006 StandoutNobel
Origins and Evolution of Antibiotic Resistance
2010 Standout
Nonorthologous replacement of lysyl-tRNA synthetase prevents addition of lysine analogues to the genetic code
2003
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
From 2000 to Mid-2010: A Fruitful Decade for the Synthesis of Pyrazoles
2011 Standout
Antibiotic Binding to Dizinc β-Lactamase L1 from Stenotrophomonas maltophilia: SCC-DFTB/CHARMM and DFT Studies
2007
Antibacterial Discovery: 21st Century Challenges
2020
Linezolid and Tiamulin Cross-Resistance in Staphylococcus aureus Mediated by Point Mutations in the Peptidyl Transferase Center
2008
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Rhodium(III)-Catalyzed Oxidative Olefination of Pyridines and Quinolines: Multigram-Scale Synthesis of Naphthyridinones
2013
Challenges of Antibacterial Discovery
2011
Biochemical Characterization of the Interactions of the Novel Pleuromutilin Derivative Retapamulin with Bacterial Ribosomes
2006
Works of Stephen Rittenhouse being referenced
Definition of the heterocyclic pharmacophore of bacterial methionyl tRNA synthetase inhibitors: potent antibacterially active non-quinolone analogues
2004
Challenges of antibacterial discovery revisited
2010
Optimisation of aryl substitution leading to potent methionyl tRNA synthetase inhibitors with excellent gram-Positive antibacterial activity
2003
Conformational restriction of methionyl tRNA synthetase inhibitors leading to analogues with potent inhibition and excellent gram-Positive antibacterial activity
2003
New Benzylidenethiazolidinediones as Antibacterial Agents
2003
Conformational Perturbation of the Envelope Glycoprotein gp120 of Human Immunodeficiency Virus Type 1 by Soluble CD4 and the Lectin Succinyl Con A
1993
1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI)
2001
Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents
2001
Susceptibilities of 123 strains of Xanthomonas maltophilia to eight beta-lactams (including beta-lactam-beta-lactamase inhibitor combinations) and ciprofloxacin tested by five methods
1994
Nanomolar Inhibitors of Staphylococcus aureus Methionyl tRNA Synthetase with Potent Antibacterial Activity against Gram-Positive Pathogens
2002
In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains
2015
Indole Naphthyridinones as Inhibitors of Bacterial Enoyl-ACP Reductases FabI and FabK
2003
Identification of a Series of Tricyclic Natural Products as Potent Broad-Spectrum Inhibitors of Metallo-β-Lactamases
2002
Defining and Combating the Mechanisms of Triclosan Resistance in Clinical Isolates ofStaphylococcus aureus
2002
Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate
1996
Selection of Retapamulin, a Novel Pleuromutilin for Topical Use
2006
Use of the Surgical Wound Infection Model To Determine the Efficacious Dosing Regimen of Retapamulin, a Novel Topical Antibiotic
2006
Comparison of three methods for determination of a single MIC of an antimicrobial agent
1994
Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI)
2002
Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections
2014
Stepwise Exposure of Staphylococcus aureus to Pleuromutilins Is Associated with Stepwise Acquisition of Mutations in rplC and Minimally Affects Susceptibility to Retapamulin
2007
Variable Sensitivity to Bacterial Methionyl-tRNA Synthetase Inhibitors Reveals Subpopulations of Streptococcus pneumoniae with Two Distinct Methionyl-tRNA Synthetase Genes
2003